[The prognostic relationship between CD56 expression and newly diagnosed multiple myeloma].

Geng, C Y; Yang, G Z; Wang, H J; Zhou, H X; Zhang, Z Y; Jian, Y; Chen, W M

Geng, C Y; Yang, G Z; Wang, H J; Zhou, H X; Zhang, Z Y; Jian, Y; Chen, W M.

Afiliação

Geng CY; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Yang GZ; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Wang HJ; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhou HX; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhang ZY; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Jian Y; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Chen WM; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Zhonghua Nei Ke Za Zhi ; 61(2): 164-171, 2022 Feb 01.

Article em Zh | MEDLINE | ID: mdl-35090251

Assuntos

Mieloma Múltiplo; Feminino; Citometria de Fluxo; Humanos; Masculino; Pessoa de Meia-Idade; Mieloma Múltiplo/diagnóstico; Prognóstico; Intervalo Livre de Progressão; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google